EXPRESSION OF ANDROGEN RECEPTOR AND PROGRAMMED DEATH-LIGAND 1 IN BREAST-TO-BRAIN-METASTASES.

被引：0
|
作者：
Qazi, Maleeha [1 ]
Jerzak, Katarzyna [2 ]
Nofech-Mozes, Sharon [3 ]
机构：
[1] Univ Toronto, Fac Med, Toronto, ON, Canada
[2] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON, Canada
[3] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
来源：
NEURO-ONCOLOGY | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
BIOM-07
引用
收藏
页码：2 / 3
页数：3
相关论文
共 50 条
  • [41] Targeting the programmed death-1/programmed death-ligand 1 axis in lymphoma
    Cheah, Chan Yoon
    Fowler, Nathan H.
    Neelapu, Sattva S.
    CURRENT OPINION IN ONCOLOGY, 2015, 27 (05) : 384 - 391
  • [42] Programmed cell death-ligand 1 expression in stromal immune cells is a marker of breast cancer outcome
    Hong, Mineui
    Kim, Jeung Won
    Kim, Min Kyoon
    Chung, Bong Wha
    Ahn, Soo Kyung
    JOURNAL OF CANCER, 2020, 11 (24): : 7246 - 7252
  • [43] Significance of the effects of chemotherapy on programmed death-ligand 1 expression in triple-negative breast cancer
    Imanishi, Seiichi
    Morishima, Hirotaka
    Gotoh, Takayoshi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (10) : 1167 - 1175
  • [44] Different Programmed Death-1/Programmed Death-Ligand 1 Expression Patterns for Each Pediatric Lymphoma Subtype
    Tamura, A.
    Yoshida, M.
    Yamamoto, N.
    Nino, N.
    Nakatani, N.
    Ichikawa, T.
    Nakamura, S.
    Saito, A.
    Kozaki, A.
    Kishimoto, K.
    Ishida, T.
    Mori, T.
    Hasegawa, D.
    Kosaka, Y.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S271 - S271
  • [45] Prevalence and predictors of androgen receptor (AR) and programmed death-ligand 1 (PD-L1) expression in BRCA1-associated and sporadic triple negative breast cancer (TNBC).
    Tung, Nadine M.
    Garber, Judy Ellen
    Torous, Vanda
    Hacker, Michele R.
    Freeman, Gordon James
    Rodig, Scott J.
    Poles, Emily
    Alexander, Brian Michael
    Lee, Larissa Janeen
    Collins, Laura C.
    Schnitt, Stuart J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [46] Immunohistochemistry Expression of Programmed Death-Ligand 1 in Colorectal Carcinoma among Nigerians
    Badmos, K. B.
    Odukoya, L. A.
    Khramtsova, G. F.
    Adebayo, L. A.
    Olopade, O., I
    Abdulkareem, F. B.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2024, 27 (11) : 1239 - 1244
  • [47] The expression and function of programmed death-ligand 1 and related cytokines in neutrophilic asthma
    Ren, Yin-Ying
    Dong, He-Ting
    Liao, Jian-Yi
    Sun, Hui-Ming
    Wang, Ting
    Gu, Wen-Jing
    Zhang, Xin-Xing
    Yan, Yong-Dong
    Ji, Wei
    Chen, Zheng-Rong
    Zhu, Can-Hong
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (23)
  • [48] Immunohistochemical expression of programmed death-ligand 1 and CD8 in glioblastomas
    El Samman, Dina Mohamed
    El Mahdy, Manal Mohamed
    Cousha, Hala Sobhy
    Kamar, Zeinab Abd El Rahman
    Mohamed, Khaled Abdel Karim
    Abou Gabal, Hoda Hassan
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2021, 55 (06) : 388 - 397
  • [49] Autophagy controls programmed death-ligand 1 expression on cancer cells (Review)
    Gao, Lijuan
    Chen, Yongshun
    BIOMEDICAL REPORTS, 2021, 15 (04)
  • [50] Programmed Death-Ligand 1 Expression in Lymphovascular Tumor Emboli in Lung Cancer
    Yeh, Yi-Chen
    Ma, Hsiu-Hsun
    Chu, Ping-Yuan
    Ho, Hsiang-Ling
    Chou, Teh-Ying
    JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (07):
12345